Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Quetiapine XR vs Mirtazapine for Sleep in Major Depression
NCT00782405Phase 3Completed
- Sponsor
- Technical University of Munich
- Start
- Oct 2008
- Primary completion
- Apr 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of quetiapine in major depressive disorder (MDD), sponsored by Technical University of Munich. Primary endpoint: Sleep Efficiency at 14 days. Started Oct 2008; status: completed.
02
Drugs
quetiapine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT00782405.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00782405.